Lenvatinib is a prescription medicine used for specific cancer indications, and its dosage is determined by the condition being treated, the treatment combination, individual patient factors, and the prescribing clinician’s assessment. Lenvatinib is available in several capsule strengths, including 4 mg and 10 mg, which may be used as part of an individualized treatment plan. The appropriate strength should never be selected based only on the information provided on a pharmacy website.
How Lenvatinib Is Administered
Lenvatinib is taken orally and is generally administered once daily according to the prescribed treatment schedule. Official prescribing information states that it may be taken with or without food and should be taken at approximately the same time each day. Capsules should be swallowed whole rather than crushed or chewed.
The prescribed dose may need to be changed or temporarily interrupted when certain adverse reactions occur. Dose adjustments can also be required for some people with significant kidney or liver impairment. These decisions should be made by the treating clinician rather than changed independently.
Missed Dose and Treatment Monitoring
If a dose is missed, patients should follow the instructions provided by their prescriber or pharmacist. The official prescribing information provides specific guidance for missed doses and advises against taking doses too close together.
Because lenvatinib can cause important adverse reactions, monitoring may include blood pressure, liver function, kidney-related findings, and other laboratory or clinical assessments during treatment. Any unusual or concerning symptoms should be discussed promptly with the treating medical team.